| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Christian J Lorenzo, Haley Fitzpatrick, Victoria Campdesuner, Justin George, Natalia Lattanzi. Pembrolizumab-Induced Ocular Myasthenic Crisis. Cureus. vol 12. issue 7. 2020-09-28. PMID:32685327. |
acetylcholine receptor (achr) antibodies returned positive at 13.9 nmol/l, and a diagnosis of ocular myasthenia gravis (omg) was made. |
2020-09-28 |
2023-08-13 |
Not clear |
| Thanatporn Threetong, Anuchit Poonyathalang, Pisit Preechawat, Panitha Jindahra, Tanyatuth Padungkiatsagul, Kavin Vanikiet. Initial Treatment Response in Ocular Myasthenia Gravis: A Comparison Between Low and Moderate Doses of Prednisolone. Clinical ophthalmology (Auckland, N.Z.). vol 14. 2020-09-28. PMID:32801613. |
to evaluate the initial treatment response to low doses of prednisolone, compared with moderate doses, in ocular myasthenia gravis (omg). |
2020-09-28 |
2023-08-13 |
Not clear |
| Roee Arnon, Tal Yahalomi, Irit Rozen-Knisbacher, Joseph Pikkel, Dina Mostovo. Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report. Case reports in ophthalmology. vol 11. issue 2. 2020-09-28. PMID:32884545. |
ocular myasthenia gravis (omg) is an autoimmune disease of the neuromuscular junction and commonly associated with other immune diseases. |
2020-09-28 |
2023-08-13 |
Not clear |
| Meabh O'Hare, Christopher Dought. Update on Ocular Myasthenia Gravis. Seminars in neurology. vol 39. issue 6. 2020-08-24. PMID:31847046. |
most patients first present with extraocular symptoms (diplopia and/or ptosis), and in 15% of cases symptoms will remain restricted to only the extraocular muscles (ocular myasthenia gravis [omg]). |
2020-08-24 |
2023-08-13 |
Not clear |
| Y Geng, J Dong, Q Zho. Rapid improvement of muscle weakness post-thymectomy indicates good long-term neurological outcome in patients with ocular myasthenia gravis. European journal of neurology. vol 26. issue 11. 2020-07-20. PMID:31299129. |
this study was conducted to evaluate whether post-thymectomy rapid remission of ocular myasthenia gravis (omg) is a prognostic indicator of good long-term neurological outcome. |
2020-07-20 |
2023-08-13 |
Not clear |
| Na Wu, Yuxiang Hu, Xiaoxuan Xu, Li Yan, Yi Cheng, Jie Rao, Yajun Wu, Xiaorong W. [Research Advances in Follicular Regulatory T Cells in Ocular Myasthenia Gravis]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. vol 42. issue 3. 2020-07-07. PMID:32616136. |
myasthenia gravis(mg)is a b cell-mediated,t cell-dependent,complements-involved autoimmune disease.ocular myasthenia gravis(omg)is a typical mg,with its symptoms limited to the extraocular muscles.the occurrence and development of a variety of autoimmune diseases including omg are closely associated with the imbalanced expression of follicular regulatory t cells(tfr cells).therefore,tfr cells may be a new research topic for omg. |
2020-07-07 |
2023-08-13 |
Not clear |
| Timothy Liang, Mark I Boulos, Brian J Murray, Sridhar Krishnan, Hans Katzberg, Karthikeyan Umapath. Analysis of electrooculography signals for the detection of Myasthenia Gravis. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. vol 130. issue 11. 2020-06-08. PMID:31541988. |
a precursor to more severe forms of myasthenia gravis (mg) is ocular mg (omg) in which the mg symptoms are localized to the eyes. |
2020-06-08 |
2023-08-13 |
Not clear |
| Supanut Apinyawasisuk, Yuda Chongpison, Chawin Thitisaksakul, Supharat Jariyakoso. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody. American journal of ophthalmology. vol 209. 2020-04-17. PMID:31562855. |
to evaluate the associated factors of conversion of ocular myasthenia gravis (omg) to generalized myasthenia gravis (gmg) among patients with seropositive acetylcholine receptor antibody (achr ab). |
2020-04-17 |
2023-08-13 |
Not clear |
| Lori Xu, Diana Castro, Joan S Reisch, Susan T Iannaccon. Response to treatment in pediatric ocular myasthenia gravis. Muscle & nerve. vol 61. issue 2. 2020-04-13. PMID:31650555. |
juvenile myasthenia gravis (jmg), a pediatric autoimmune neuromuscular junction disorder, includes generalized (gmg), and ocular (omg) variants. |
2020-04-13 |
2023-08-13 |
Not clear |
| Tina M Hendricks, M Tariq Bhatti, David O Hodge, John J Che. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study. American journal of ophthalmology. vol 205. 2020-03-06. PMID:31077669. |
to establish the incidence of ocular myasthenia gravis (omg) as well as identify determinants of transformation to generalized myasthenia gravis (gmg) using a population-based record-linkage system. |
2020-03-06 |
2023-08-13 |
Not clear |
| Ran An, Yan Li, Baiyuan Yang, Hui Wang, Yanming X. Rare Co-occurrence of Ocular Myasthenia Gravis and Thyroid-Associated Orbitopathy (Ophthalmopathy) in an Individual With Hypothyroidism. Frontiers in endocrinology. vol 9. 2020-02-25. PMID:30809198. |
ocular myasthenia gravis (ocular mg, omg) shares many clinical features with thyroid-associated orbitopathy or thyroid-associated ophthalmopathy (tao). |
2020-02-25 |
2023-08-13 |
Not clear |
| Liis Sabre, Paul Maddison, Sui H Wong, Girija Sadalage, Philip A Ambrose, Gordon T Plant, Anna R Pung. miR-30e-5p as predictor of generalization in ocular myasthenia gravis. Annals of clinical and translational neurology. vol 6. issue 2. 2020-02-18. PMID:30847357. |
to determine a predictive factor for the risk of conversion from ocular myasthenia gravis (omg) to generalized mg (gmg) in a prospective study. |
2020-02-18 |
2023-08-13 |
Not clear |
| Sumitha Gounden, Bonne Lee, Ross Mellick, Susan B Rutkowski, James W Middleto. Ocular myasthenia gravis in a person with tetraplegia presenting challenges in diagnosis and management. Spinal cord series and cases. vol 2. 2019-11-20. PMID:28053739. |
we report the first case of ocular myasthenia gravis (omg) in a patient with complete tetraplegia, highlighting diagnostic and management challenges. |
2019-11-20 |
2023-08-13 |
Not clear |
| Yong Zhang, Xiao Jia, Yan Xia, Hao Li, Fei Chen, Jie Zhu, Xiuying Zhang, Yanyan Zhang, YuZhong Wang, Yanan Xu, Meng Pan, Xiaoyu Huang, Tingyan Yu, Linlin Fu, Chenghua Xiao, Deqin Gen. Altered expression of transcription factors IRF4 and IRF8 in peripheral blood B cells is associated with clinical severity and circulating plasma cells frequency in patients with myasthenia gravis. Autoimmunity. vol 51. issue 3. 2019-10-03. PMID:29569949. |
in the present study, we aimed to measure the expression levels of irf4 and irf8 in b cells from patients with myasthenia gravis (mg) and to investigate whether the expression of irf4 and irf8 associates with pathogenesis of mg. a total of 35 anti-acetylcholine receptor (achr) antibody (ab)-positive patients with mg [20 generalized mg (gmg) and 15 ocular mg (omg) and 25 healthy donors were recruited in this study. |
2019-10-03 |
2023-08-13 |
Not clear |
| Ya Jun Wu, Li Yan, Yu Xiang Hu, Jie Rao, Xiao Xuan Xu, Yi Cheng, Na Wu, Xiao Rong W. [Research Advances in Ocular Myasthenia Gravis]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. vol 41. issue 3. 2019-09-05. PMID:31282337. |
ocular myasthenia gravis(omg)is an autoimmune disease caused by neuromuscular junction transmission disorders and manifested mainly as fluctuating blepharoptosis and diplopia,with the extraocular muscles as the main involveed sites.while the pathogenesis of omg remains unclear,some antibodies,complements,and cytokines may be the contributing factors.the diagnosis and treatment of omg have been defined in recent years.this article reviews the pathogenesis,diagnosis,and treatment of omg. |
2019-09-05 |
2023-08-13 |
Not clear |
| Kelvin Y Teo, Sharon L Tow, Benjamin Haaland, Tushar D Gosavi, Loo Jing-Liang, L O Yew Long, Dan Mile. Low conversion rate of ocular to generalized myasthenia gravis in Singapore. Muscle & nerve. vol 57. issue 5. 2019-03-27. PMID:28981152. |
ocular myasthenia gravis (omg) is a common condition of the neuromuscular junction that may convert to generalized myasthenia gravis (gmg). |
2019-03-27 |
2023-08-13 |
Not clear |
| Elizabeth Fortin, Dean M Cestari, David H Weinber. Ocular myasthenia gravis: an update on diagnosis and treatment. Current opinion in ophthalmology. vol 29. issue 6. 2018-12-21. PMID:30281029. |
ocular myasthenia gravis (omg) is a variant of the disease that is confined to the ocular muscles but frequently becomes generalized over time. |
2018-12-21 |
2023-08-13 |
Not clear |
| Giuliana Galassi, Marco Mazzoli, Alessandra Ariatti, Shaniko Kaleci, Franco Valzania, Paolo F Nichell. Antibody profile may predict outcome in ocular myasthenia gravis. Acta neurologica Belgica. vol 118. issue 3. 2018-12-11. PMID:29858757. |
an unsolved issue remains whether there are clinical and immunological features to predict in a single patient the risk of conversion from ocular myasthenia gravis (omg) to generalized disease (gmg) as 50-60% of patients may progress within 1-2 years since onset. |
2018-12-11 |
2023-08-13 |
human |
| Marco Mazzoli, Alessandra Ariatti, Franco Valzania, Shaniko Kaleci, Manuela Tondelli, Paolo F Nichelli, Giuliana Galass. Factors affecting outcome in ocular myasthenia gravis. The International journal of neuroscience. vol 128. issue 1. 2018-07-06. PMID:28625092. |
50%-60% of patients with ocular myasthenia gravis (omg) progress to generalized myasthenia gravis (gmg) within two years. |
2018-07-06 |
2023-08-13 |
Not clear |
| Goran Rakocevic, Mark Moster, Mary Kay Floete. Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment? BMC neurology. vol 17. issue 1. 2018-01-19. PMID:28592233. |
seronegative ocular myasthenia gravis (omg) is diagnosed by ocular symptoms with supporting sfemg, typically of frontalis or extensor digitorum muscles. |
2018-01-19 |
2023-08-13 |
Not clear |